Intra-Cellular Therapies Inc (NASDAQ:ITCI)

Delayed Data
As of 4:04pm ET
 +0.19 / +0.33%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Intra-Cellular Therapies Inc have a median target of 70.00, with a high estimate of 90.00 and a low estimate of 57.00. The median estimate represents a +20.86% increase from the last price of 57.92.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Intra-Cellular Therapies Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.73%
Growthannually 13.81%


Growthquarterly 33.43%
Growthannually 160.96%
Key to the earnings and sales forecast charts.